Rucaparib
Pharmaceutical drug
>
Rucaparib, sold under the brand name Rubraca, is a PARP inhibitor used as an anti-cancer agent. Rucaparib is a first-in-class pharmaceutical drug targeting the DNA repair enzyme poly-ADP ribose polymerase-1. It is taken by mouth. Wikipedia
ATC code: L01XK03 (WHO)
Elimination half-life: 17–19 hours
Other names: CO-338, AG-014699, PF-0136738, PF-01367338
Pronunciation: /ruːˈkæpərɪb/ roo-KAP-ər-ib